-
EP0584266
European procedure
Extract from the Register of European Patents
EP About this file: EP0584266
| EP0584266 - RECOMBINANT VIRUS EXPRESSING CARCINOEMBRYONIC ANTIGEN AND METHODS OF USE THEREOF [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 10.07.2004 Database last updated on 14.05.2024 | Most recent event Tooltip | 05.10.2005 | Change: Appeal number | Applicant(s) | For all designated states THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institute of Health, Office of Technology Transfer, Westwood Building, Box OTT Bethesda, MD 20892-9902 / US | [N/P] |
| Former [1994/09] | For all designated states THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institute of Health, Office of Technology Transfer, Westwood Building, Box OTT Bethesda, MD 20892-9902 / US | Inventor(s) | 01 /
SCHLOM, Jeffrey 10525 Tyler Terrace Potomac, MD 20854 / US | 02 /
KANTOR, Judith 1096 Larkspur Terrace Rockville, MD 20850 / US | [1994/09] | Representative(s) | Brown, David Leslie, et al Haseltine Lake Kempner LLP Redcliff Quay 120 Redcliff Street Bristol BS1 6HU / GB | [N/P] |
| Former [2002/02] | Brown, David Leslie, et al Haseltine, Lake & Co, Imperial House, 15-19 Kingsway London WC2B 6UD / GB | ||
| Former [2001/41] | Brown, David Leslie Page Hargrave Southgate Whitefriars Lewins Mead Bristol BS1 2NT / GB | ||
| Former [1994/09] | Harvey, David Gareth Graham Watt & Co. Riverhead Sevenoaks Kent TN13 2BN / GB | Application number, filing date | 92913153.0 | 06.05.1992 | [1994/09] | WO1992US03843 | Priority number, date | US19910695024 | 06.05.1991 Original published format: US 695024 | US19920879649 | 06.05.1992 Original published format: US 879649 | [1994/09] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO9219266 | Date: | 12.11.1992 | Language: | EN | [1992/28] | Type: | A1 Application with search report | No.: | EP0584266 | Date: | 02.03.1994 | Language: | EN | The application published by WIPO in one of the EPO official languages on 12.11.1992 takes the place of the publication of the European patent application. | [1994/09] | Type: | B1 Patent specification | No.: | EP0584266 | Date: | 03.09.2003 | Language: | EN | [2003/36] | Search report(s) | International search report - published on: | US | 12.11.1992 | (Supplementary) European search report - dispatched on: | EP | 15.02.1995 | Classification | IPC: | C12N15/86, C12N15/12, A61K39/00 | [2003/36] | CPC: |
C07K14/70503 (EP,US);
A61P35/00 (EP);
C07K14/705 (EP,US);
A61K38/00 (EP,US);
A61K39/00 (EP,US);
C12N2799/023 (EP,US)
|
| Former IPC [1995/13] | C12N15/86, C12N15/12, A61K37/02 | ||
| Former IPC [1994/09] | A61K39/12 | Designated contracting states | AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LI, LU, MC, NL, SE [1994/09] | Title | German: | KARCINOEMBRYONALE ANTIGEN EXPREMIERENDE REKOMBINANTE VIREN UND METHODEN IHRER ANWENDUNG | [1994/09] | English: | RECOMBINANT VIRUS EXPRESSING CARCINOEMBRYONIC ANTIGEN AND METHODS OF USE THEREOF | [1994/09] | French: | ANTIGENE CARCINO-EMBRYONNAIRE EXPRIMANT UN VIRUS RECOMBINE ET SES PROCEDES D'UTILISATION | [1994/09] | Biological material | This application mentions deposited biological material, check the file for details | Entry into regional phase | 26.11.1993 | National basic fee paid | 26.11.1993 | Search fee paid | 26.11.1993 | Designation fee(s) paid | 26.11.1993 | Examination fee paid | Examination procedure | 24.11.1992 | Request for preliminary examination filed International Preliminary Examining Authority: GB | 29.11.1993 | Examination requested [1994/09] | 05.06.1997 | Despatch of a communication from the examining division (Time limit: M06) | 04.12.1997 | Reply to a communication from the examining division | 05.05.1998 | Despatch of a communication from the examining division (Time limit: M06) | 11.11.1998 | Reply to a communication from the examining division | 13.10.2000 | Despatch of communication that the application is refused, reason: substantive examination {1} | 13.11.2002 | Communication of intention to grant the patent | 05.02.2003 | Fee for grant paid | 05.02.2003 | Fee for publishing/printing paid | Appeal following examination | 08.12.2000 | Appeal received No. T0282/01 | 12.02.2001 | Statement of grounds filed | 17.07.2002 | Result of appeal procedure: remittal for grant | 17.07.2002 | Date of oral proceedings | 02.08.2002 | Minutes of oral proceedings despatched | Divisional application(s) | EP02015597.4 Application deemed to be withdrawn : 17.08.2002 | Opposition(s) | 04.06.2004 | No opposition filed within time limit [2004/35] | Fees paid | Renewal fee | 18.04.1994 | Renewal fee patent year 03 | 26.04.1995 | Renewal fee patent year 04 | 28.05.1996 | Renewal fee patent year 05 | 20.05.1997 | Renewal fee patent year 06 | 14.05.1998 | Renewal fee patent year 07 | 14.05.1999 | Renewal fee patent year 08 | 16.05.2000 | Renewal fee patent year 09 | 05.03.2001 | Renewal fee patent year 10 | 27.05.2002 | Renewal fee patent year 11 | 27.05.2003 | Renewal fee patent year 12 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XY]EP0263933 (MOLECULAR DIAGNOSTICS INC [US]) [X] 9,10 * page 11, paragraph L *[Y] 1-6,11-13 | [Y] - ESTIN ET AL., "Recombinant vaccinia virus vaccine against the human melanoma antigen p97 for use in immunotherapy", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA., WASHINGTON US, (198802), vol. 85, pages 1052 - 1056 [Y] 1-6,11-13 * page 1052, column L, paragraph L * | [PX] - KAUFMAN ET AL., "A recombinant vaccinia virus expressing human carcinoembryonic antigen [CEA]", INTERNATIONAL JOURNAL OF CANCER, (19910730), vol. 48, no. 6, pages 900 - 907 [PX] 1-8,11-13 * the whole document * | International search | [Y] - Proceedings National Academy of Sciences, Volume 79, issued December 1982, M. MACKETT et al., "Vaccinia virus: A Selectable Eukaryotic Cloning and Expression Vector", pages 7415-7419, see entire article. | [Y] - Cancer Research, Volume 45, issued November 1985, R. MURARO et al., "Definition by Monoclonal antibodies of a Repertoire of Epitopes on Carcinoembryonic antigen Differentially Expressed in Human Colon Carcinomas versus Normal Adult Tissues", pages 5769-5780, especially pages 5770-5771. | [Y] - Biochemical and Biophysical Research Communications, Volume 142, No. 2, issued 30 January 1987, S. OIKAWA et al., "Primary structure of Human Carcinoembryonic Antigen (CEA) Deduced from cDNA Sequence", pages 511-518, especially figures 2 and 3. | [Y] - Nature, Volume 326, issued 30 April 1987, R. LATHE et al., "Tumour Prevention and Rejection with Recombinant Vaccinia", pages 878-880, see entire article. | [Y] - Cancer Immunology Immunotherapy, Volume 20, issued 1988, M. HOSOKAWA et al., "Improved Therapeutic effects of Interleukin 2 After the Accumulation of Lymphokine-Activated Killer Cells in Tumor Tissue of Mice Previously Treated with Cyclophosphamide", pages 250-255, especially pages 252-254. |